• BMB Reports
• /
• 제38권1호
• /
• pp.58-64
• /
• 2005

Myo-inositol monophosphate phosphatase (IMPP) is a key enzyme in the phosphoinositide cell-signaling system. This study found that incubating the IMPP from a porcine brain with pyridoxal-5'-phosphate (PLP) resulted in a time-dependent enzymatic inactivation. Spectral evidence showed that the inactivation proceeds via the formation of a Schiff's base with the amino groups of the enzyme. After the sodium borohydride reduction of the inactivated enzyme, it was observed that 1.8 mol phosphopyridoxyl residues per mole of the enzyme dimer were incorporated. The substrate, myo-inositol-1-phosphate, protected the enzyme against inactivation by PLP. After tryptic digestion of the enzyme modified with PLP, a radioactive peptide absorbing at 210 nm was isolated by reverse-phase HPLC. Amino acid sequencing of the peptide identified a portion of the PLP-binding site as being the region containing the sequence L-Q-V-S-Q-Q-E-D-I-T-X, where X indicates that phenylthiohydantoin amino acid could not be assigned. However, the result of amino acid composition of the peptide indicated that the missing residue could be designated as a phosphopyridoxyl lysine. This suggests that the catalytic function of IMPP is modulated by the binding of PLP to a specific lysyl residue at or near its substrate-binding site of the protein.

• BMB Reports
• /
• 제36권4호
• /
• pp.409-416
• /
• 2003

The isoform 1 of cyclodextrin glycosyltransferase (CGTase, EC 2.4.1.19) from Paenibacillus sp. A11 was purified by a preparative gel electrophoresis. The importance of histidine, tryptophan, tyrosine, and carboxylic amino acids for isoform 1 activity is suggested by the modification of the isoform 1 with various group-specific reagents. Activity loss, when incubated with diethylpyrocarbonate (DEP), a histidine modifying reagent, could be protected by adding 25 mM methyl-$\beta$-cyclodextrin substrate prior to the modification. Inactivation kinetics of isoform 1 with DEP resulted in second-order rate constants ($k_{inactivation}$) of $29.5\;M^{-1}s^{-1}$. The specificity of the DEP-modified reaction for the histidine residue was shown by the correlation between the loss of isoform activity and the increase in the absorbance at 246 nm of N-carbethoxyhistidine. The number of histidines that were modified by DEP in the absence and presence of a protective substrate was estimated from the increase in the absorbance using a specific extinction coefficient of N-carbethoxyhistidine of $3,200\;M^{-1}cm^{-1}$. It was discovered that methyl-$\beta$-CD protected per mole of isoform 1, two histidine residues from the modification by DEP. To localize essential histidines, the native, the DEP-modified, and the protected forms of isoform 1 were digested by trypsin. The resulting peptides were separated by HPLC. The peptides of interest were those with $R_t$ 11.34 and 40.93 min. The molecular masses of the two peptides were 5,732 and 2,540 daltons, respectively. When the data from the peptide analysis were checked with the sequence of CGTase, then His-140 and His-327 were identified as essential histidines in the active site of isoform 1.

• Journal of Microbiology
• /
• 제34권3호
• /
• pp.270-273
• /
• 1996

Micrococcus luteus purine nucleoside phosphorylase (PNP) has been purified and characterized. The physical and kinetic properties have been described previously. Chemical modification of the enzyme was attempted to gain insight on the active site. The enzyme was inactivated in a time-dependent manner by the arginine- specific modifying reagent phenylglyoxal. There was a linear relationship between the observed rate of inactivation and the phenylglyoxal concentration. At 30 $^{\circ}C$ the bimolecular rate constant for the modification was 0.015 $min^{-1}mM^{-1}$ in 50 mM $NaHCO_3$ buffer, pH 7.5. The plot of logk versus log phenylglyoxal concentration was a strainght line with a slope value of 0.9, indicating that modification of one arginine residue was needed to inactivate the enzyme. Preincubation with saturated solutions of substrates protected the enzyme from inhibition of phenylglyoxal, indicating that reactions with phenylglyoxal were directed at arginyl residues essential for the catalytic functioning of the enzyme.

• Journal of Microbiology and Biotechnology
• /
• 제13권4호
• /
• pp.613-619
• /
• 2003

The polyketide backbone of rifamycin B is assembled by the type I rifamycin polyketide synthase (PKS) encoded by the rifA-rifE genes. In order to produce novel analogs of rifamycin via engineering of the PKS genes, inactivation of the ${\beta}-ketoacyl:acyl$ carrier protein reductase (KR) domain in module 8 of rifD, by site-specific mutagenesis of the NADPH binding site, was attempted. Module 8 contains a nonfunctional dehydratase (DH) domain and a functional KR domain that is involved in the reduction of the ${\beta}-carbonyl$ group, resulting in the C-21 hydroxyl of rifamycin B. This mutant strain produced linear polyketides, from tetraketide to octaketide, which were also produced by a rifD-disruption mutant as a consequence of premature termination of the polyketide assembly. Another attempt to replace the DH domain of module 7, which has been considered nonfunctional, with a functional homolog derived from module 7 of rapamycin-producing PKS also resulted in the production of linear polyketides, including the heptaketide intermediate and its precursors. Premature release of the carbon chain assembly intermediates is an unusual property of the rifamycin PKS. that is not seen in other PKSs such as the erythromycin PKS.

• BMB Reports
• /
• 제29권4호
• /
• pp.277-285
• /
• 1996

In Pseudomonas fluorescens grown on malonate as sole carbon source, acetyl-CoA synthetase was induced, suggesting that malonate is metabolized through acetate and then acetyl-CoA. Acetyl-CoA synthetase was purified 18.6-fold in 4 steps to apparent homogeneity. The native molecular mass of the enzyme estimated by a native acrylamide gel electrophoresis was 130 kDa. The enzyme was composed of two identical subunits with a molecular mass of 67 kDa. Optimum pH was 70. The acetyl-CoA synthetase showed typical Michaelis-Menten kinetics for the substrates, acetate, ATP and CoA, whose $K_m$ values were calculated to be 33.4, 74.8, and 40.7 mM respectively. Propionate. butyrate and pentanoate were also used as substrates by the enzyme, but the rate of the formation of the CoA derivatives was decreased in the order of the increase in carbon number. The enzyme was inhibited by the group-specific reagents diethylpyro-carbonate, 2,3-butanedione, pyridoxal-5'-phosphate and N-bromosuccinimide. In the presence of substrates the inactivation rate of the enzyme, by all of the group-specific reagents mentioned above decreased, indicating the presence of catalytically essential histidine, arginine, lysine and tryptophan residues at or near the active site. Preincubation of the enzyme with ATP, $Mg^{2+}$ resulted in the increase of its susceptibility to diethylpyrocarbonate, suggesting that ATP, $Mg^{2+}$ may induce a conformational change in the active site exposing the essential histidine residue to diethylpyrocarbonate. The enzyme was acetylated in the presence of acetyl-CoA, indicating that this is one of acyl-enzyme.

• BMB Reports
• /
• 제32권3호
• /
• pp.294-298
• /
• 1999

Myo-inositol monophosphate phosphatase is a key enzyme in the phosphoinositide cell-signaling system. Incubation of myo-inositol monophosphate phosphatase from porcine brain with N-bromosuccinimide (NBS) resulted in a time-dependent loss of enzyme activity. The inactivation followed pseudo-first-order kinetics with the second-order rate constant of $3.8{\times}10^3\;M^{-1}min^{-1}$. The time course of the reaction was significantly affected by the substrate myo-inositol-1-phosphate, which afforded complete protection against the loss of catalytic activity. Spectrophotometric studies indicated that about one oxindole group per molecule of enzyme was formed following complete loss of enzymatic activity. It is suggested that the catalytic function of myo-inositol monophosphate phosphatase is modulated by the binding of NBS to a specific tryptophan residue at or near the substrate binding site of the enzyme.

• 약학회지
• /
• 제39권6호
• /
• pp.645-653
• /
• 1995

Dibenamine inhibited [$^{3}$H]quinuclidinyl benzilate ([$^{3}$H]QNB) binding in both concentration and incubation time-dependent manners. The $IC_{50}$/ value of dibenamine for the inhibition of the specific binding of 100 pM [$^{3}$'H]QNB following incubation of cerebral microsomes with dibenamine at 37.deg. C for 15 min was 20.mu.M. Dibenamine irreversibly decreased the binding site concentration for [$^{3}$H]QNB binding without affecting the affinity of [$^{3}$H]QNB for the muscarinic receptor. Analysis of the pirenzepine inhibition curve of [$^{3}$H]QNB binding to cerebral microsomes indicated the presence of two receptor subtypes with high(M$_{1}$ receptor, Ki=5nM) and low (M$_{2}$ receptor, Ki=160nM) affinity for pirenzepine. However, dibenamine(20.mu.M) treatment under the condition employed in these experiments caused steepening of the pirenzepine competition curve. The Ki value for pirenzepine in dibenamine treated-microsomes was approximately 120nM. suggesting a selective decrease in the number of M$_{1}$ receptor. Although dibenamine also inhibited [$^{3}$H]QNB binding to ventricular microsomes with $IC_{50}$/ value of 120.mu.M, the sensitivity for dibenamine in the ventricle was much lower than that in the cerebrum. These results indicate that dibenamine at low concentrations welectively inactivates the muscarinic M$_{1}$ receptor.

• 미생물학회지
• /
• 제45권2호
• /
• pp.200-207
• /
• 2009

Erythritol 생합성에 중요한 효소인 erythritol 4-phosphate dehydrogenase를 Penicillium sp. KJ81로부터 분리 정제하여 효소의 특성을 조사한 결과 다음과 같은 결론을 얻었다. Erythritol 4-phosphate dehydrogenase의 최적 생산 조건은 30% sucrose, 0.5% yeast extract, 0.5% $(NH_4)_2SO_4$, 0.1% $KH_2PO_4$ 그리고 0.05% $MgCl_2$ (pH 7.0) 배지에서 1 vvm aeration, 교반속도 200 rpm, $37^{\circ}C$로 Penicillium sp. KJ81을 배양한 결과 8일 배양 시 최대의 생산량을 보였다. Penicillium sp. KJ81주의 균체 추출액으로부터 ultrafiltration, 조제용 disc gel electrophoresis를 이용하여 erythritol 4-phosphate dehydrogenase를 분리 정제하였다. 최종 수율은 33%이었으며 정제배수는 39.5였다. 정제된 효소의 pI값은 4.6으로, erythrose 4-phosphate에 특이적으로 반응하였으며, Km값은 1.07mM이었다. Native-PAGE에서 single band를 보인 효소의 분자량은 약 1,500 kDa이었다. 효소활성의 최적 pH와 온도는 pH 7.0, $30^{\circ}C$였으며, 효소는 pH 4.0~9.0, 그리고 $30^{\circ}C$까지 안정하였다. 다양한 금속이온 중 $Cu^{2+}$, $Zn^{2+}$에 의하여 효소의 활성이 저해되었다. 다양한 아미노산 반응 잔기 변형시약 중 iodine과 NBS에 의해 효소의 활성이 저해되는 것을 확인하였다.

• Archives of Pharmacal Research
• /
• 제25권5호
• /
• pp.685-690
• /
• 2002

The mitogen-stimulated serine/threonine kinase $p70^{S6k}$ plays an important role in the progression of cells from $G_0/G$_1$$ to S phase of the cell cycle by translational up-regulation of a family of mRNA transcripts family of mRNA transcripts which contain polypyrimidine tract at their 5 transcriptional start site. Here, we report that $p70^{S6k}$ was constitutively phosphorylated and activated to various degrees in serum-deprived AGS, A2058, HT-1376, MG63, MCF7, MDA-MB-435S, MDA-MB-231 and MB-157. Rapamycin treatment induced a significant dephosphorylation and inactivation of $p70^{S6k}$ in all cancer cell lines, while wortmannin, a specific inhibitor of PI3-K, caused a mild dephosphorylation of $p70^{S6k}$ in AGS, MDA-MB-435S and MB-157. In addition, SQ20006, methylxanthine phosphodiesterase inhibitor, reduced the phosphorylation of $p70^{S6k}$ in all cancer cells tested. Consistent with inhibitory effect of rapamycin on $p70^{S6k}$ activity, rapamycin inhibited [$^3H$]-thymidine incorporation and increased the number of cells at $G_{0}G_{1}$ phase. Furthermore, these inhibitory effects were accompanied by the decrease in growth of cancer cells. Taken together, the results indicate that the antiproliferative activity of rapamycin might be attributed to cell cycle arrest at $G_{0}G_{1}$ phase in human cancer cells through the inhibition of constitutively activated $p70^{S6k}$ of cancer cells and suggest $p70^{S6k}$ as a potential target for therapeutic strategies aimed at preventing or inhibiting tumor growth.

• Journal of Chest Surgery
• /
• 제35권2호
• /
• pp.94-101
• /
• 2002

배경: 모든 조직판막은 면역학적인 불활성화 및 내구성 강화를 위하여 이식 전 터치를 필요로 한다. 그러나 조직 판막은 이식 후 점차적인 석회화 과정을 보이며, 결국 판막의 기능을 상실하게 된다. 최근 석회화 과정의 병리기전에 관한 연구에서는 이식된 조직판막의 석회화 부위에서 정상 골성석회화에 관련하는 결합단백이 검출되기에 이르렀다. 본 실험은 이러한 결합단백의 공통 결합부인 RGD(Arg-Gly-Asp)를 갖는 RGDStetrapeptide를 이식 전 조직에 처치하여 이식 후 숙주의 골성석회화 관련 결합단백의 결합을 억제하는 것이 석회화과정에 영향을 줄 수 있는가를 확인하기 위하여 계획되었다. 대상 및 방법: 실험은 소 심낭을 0.6%글루타알데하이드에 처치한 후 이를 작은 절편으로 나누어 1군은 생리식염수에서 60분간 처리, 2 군은 RGDS와 같은 분자량을 갖는 0.5% GRSD tetrapeptide에서 60분간 처리, 3군은 0.5% RGDS에서 30분간 처리, 4군은 0.5% RGDS에서 60분간 처리, 5군은 0.5% RGDS에서 120분간 처리하였다. 이렇게 처리된 소 심낭절편을 흰쥐의 복부 피하에 이식하였으며, 30일 후 채취하여 방사선 검사와 생화학적 검사 및 조직학적 검사를 시행하여 이식절편의 석회화 정도를 판정하였다. 결과: 이식절편을 방사선 촬영 후, 측정한 음영도는 3, 4, 5군에서 48.00$\pm$3.57, 43.67$\pm$2.31, 42.58$\pm$2.47로 1, 2군의 68.42$\pm$3.06, 64.25+5.58과 통계학적인 차이를 보였다(p<7.05). 1군과 2군간의 유의한 차이는 없었다(p=0.105). 생화학적 검사에서 이식절편의 칼슘 총량은 1군 33.09$\pm$6.59mg, 2군 28.12+5.5mg,, 3군 25.42+7.67mg,, 4군 20.51$\pm$5.11mg, 5군 15.43$\pm$4.25mg을 보여, 5군이 1, 2, 3군에 비하여 통계적으로 유의하게 석회화 정도가 감소되어 있었다(<0.05). 1군과 2군간에 유의한 차이는 없었다(p=0.388). 조직학적 검사에서는 1, 2군에서 현저한 칼슘침착을 확인할 수 있었으며 3, 4군은 적은 양의 칼슘침착을 보여주는 반면, 5군에서는 뚜렷할 칼슘 침착 부를 확인할 수 없었다. 결론: 이상의 결과에서 이식 전 RGDS tetrapeptide를 처치하는 것이 흰쥐의 똑부 피하에 이식된 소 심낭절편의 석회화를 억제하는 효과가 있음을 확인할 수 있었다.